1990
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan.
Kent K, Cleman M, Cowley M, Forman M, Jaffe C, Kaplan M, King S, Krucoff M, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan. The American Journal Of Cardiology 1990, 66: 279-284. PMID: 2195864, DOI: 10.1016/0002-9149(90)90836-p.Peer-Reviewed Original ResearchConceptsOxygen-carrying perfluorochemical emulsionFluosol perfusionAngioplasty patientsMyocardial ischemiaPerfluorochemical emulsionBaseline levelsGlobal left ventricular ejection fractionLeft ventricular ejection fractionPercutaneous transluminal coronary angioplastyRegional wall dysfunctionSevere anginal painTransluminal coronary angioplastyVentricular ejection fractionST-segment changesAnginal painGreen Cross CorporationCoronary angioplastyEjection fractionMulticenter trialRoutine angioplastyVentricular functionBalloon occlusionBalloon deflationPatient populationBalloon inflation
1989
Predictors of success in percutaneous transluminal coronary angioplasty of chronic total occlusions
LaVeau P, Remetz M, Cabin H, Hennecken J, McConnell S, Rosen R, Cleman M. Predictors of success in percutaneous transluminal coronary angioplasty of chronic total occlusions. The American Journal Of Cardiology 1989, 64: 1264-1269. PMID: 2589190, DOI: 10.1016/0002-9149(89)90565-1.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyChronic total occlusionTotal occlusionAngiographic variablesClinical durationCoronary angioplastySuccess rateUnderwent repeat percutaneous transluminal coronary angioplastyRepeat percutaneous transluminal coronary angioplastySuccessful percutaneous transluminal coronary angioplastyEmergency coronary artery bypassNon-Q-wave infarctionCoronary artery bypassAcute myocardial infarctionQ-wave infarctionClinical occlusionArtery bypassMean durationMyocardial infarctionDilatation sitePredictors of successLow success rateInfarctionPatients
1987
Silent ischemia during coronary occlusion produced by balloon inflation: Relation to regional myocardial dysfunction
Wohlgelernter D, Jaffe C, Cabin H, Yeatman L, Cleman M. Silent ischemia during coronary occlusion produced by balloon inflation: Relation to regional myocardial dysfunction. Journal Of The American College Of Cardiology 1987, 10: 491-498. PMID: 2957410, DOI: 10.1016/s0735-1097(87)80189-4.Peer-Reviewed Original ResearchMeSH KeywordsAngina PectorisAngioplasty, BalloonCoronary DiseaseEchocardiographyElectrocardiographyHeartHumansProspective StudiesConceptsBalloon inflationAsymptomatic groupCoronary angioplastyMyocardial ischemiaPercutaneous transluminal coronary angioplastyRegional left ventricular dysfunctionGlobal left ventricular wall motionTwo-dimensional echocardiographic recordingsLeft ventricular dysfunctionStable exertional anginaAbsence of anginaSilent myocardial ischemiaTransluminal coronary angioplastyRegional myocardial dysfunctionLeft ventricular wall motionST-segment changesSignificant differencesVentricular wall motionPain interviewExertional anginaSilent ischemiaVentricular dysfunctionObstructive lesionsEchocardiographic assessmentComorbid conditions
1986
Percutaneous transluminal coronary angioplasty of the “culprit lesion” for management of unstable angina pectoris in patients with multivessel coronary artery disease
Wohlgelernter D, Cleman M, Highman H, Zaret B. Percutaneous transluminal coronary angioplasty of the “culprit lesion” for management of unstable angina pectoris in patients with multivessel coronary artery disease. The American Journal Of Cardiology 1986, 58: 460-464. PMID: 2944366, DOI: 10.1016/0002-9149(86)90015-9.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyMultivessel coronary artery diseaseCoronary artery diseaseCulprit lesionTransluminal coronary angioplastyUnstable angina pectorisUnstable anginaAngina pectorisArtery diseaseCoronary angioplastyLong-term clinical improvementIntracoronary filling defectsOptimal medical therapyUnstable angina refractoryFeasible therapeutic optionPrimary success rateProcedure-related complicationsAngina refractoryRecurrent anginaSubtotal obstructionAngiographic evidenceClinical improvementCoronary thrombosisMedical therapyCoronary lesionsRegional myocardial dysfunction during coronary angioplasty: Evaluation by two-dimensional echocardiography and 12 lead electrocardiography
Wohlgelernter D, Cleman M, Highman H, Fetterman R, Duncan J, Zaret B, Jaffe C. Regional myocardial dysfunction during coronary angioplasty: Evaluation by two-dimensional echocardiography and 12 lead electrocardiography. Journal Of The American College Of Cardiology 1986, 7: 1245-1254. PMID: 2940283, DOI: 10.1016/s0735-1097(86)80143-7.Peer-Reviewed Original ResearchConceptsLeft ventricular dysfunctionRegional left ventricular dysfunctionTwo-dimensional echocardiographyCoronary arteryVentricular dysfunctionCoronary angioplastyIschemic effectsBalloon inflationGroup BNormal left ventricular functionPercutaneous transluminal coronary angioplastyLead electrocardiographic recordingsMagnitude of dysfunctionTransient total occlusionEvidence of ischemiaIschemic electrocardiographic changesTransluminal coronary angioplastyLeft ventricular functionLeft ventricular wall motionRegional myocardial dysfunctionWall motion abnormalitiesRecovery of functionRegional left ventricular wall motionOnset of dysfunctionVentricular wall motionOxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
Jaffe C, Wohlgelernter D, Highman H, Cleman M. Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function. Progress In Clinical And Biological Research 1986, 211: 21-7. PMID: 2938192.Peer-Reviewed Original Research